News
Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...
Costa Rica: A recent systematic review published in the Cureus Journal of Medical Science has shed light on the potential of ...
27mon MSN
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
13hOpinion
The Star on MSNDR NELLY: Kenya’s quiet shift in diabetes and obesity treatmentKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...
Explore more
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after stopping their prescription, ...
GLP-1 receptor agonist drugs like Ozempic help people manage type 2 diabetes. Foods like Greek yogurt and avocados can't do ...
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.
1h
News-Medical.Net on MSNWeight regain observed in patients after ending obesity drug treatmentPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...
Two drugs commonly known as Mounjaro and Trulicity, will not be available for online sale to non-Canadian residents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results